Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 3391Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others

REVIEW ARTICLE

Trends in clinical trials of dengue vaccine

Marimuthu Priya, Ravinder Jamuna Rani

Year : 2016| Volume: 7| Issue : 4 | Page no: 161-164

   This article has been cited by
 
1 Knowledge, attitudes and bite prevention practices and estimation of productivity of vector breeding sites using a Habitat Suitability Score (HSS) among households with confirmed dengue in the 2014 outbreak in Dar es Salaam, Tanzania
Daniel Msellemu,Tegemeo Gavana,Hassan Ngonyani,Yeromin P. Mlacha,Prosper Chaki,Sarah J. Moore,Mary Hayden
PLOS Neglected Tropical Diseases. 2020; 14(7): e0007278
[Pubmed]  [Google Scholar] [DOI]
2 Commentary on “Current Challenges in the Development of Vaccines and Drugs Against Emerging Vector-borne Diseases” by Professor Kwang-sun Kim, Pusan National University, Republic of Korea
John F. Honek
Current Medicinal Chemistry. 2019; 26(17): 3201
[Pubmed]  [Google Scholar] [DOI]
3 Cardol triene inhibits dengue infectivity by targeting kl loops and preventing envelope fusion
Parichat Kanyaboon,Thanaphon Saelee,Aphinya Suroengrit,Kowit Hengphasatporn,Thanyada Rungrotmongkol,Warinthorn Chavasiri,Siwaporn Boonyasuppayakorn
Scientific Reports. 2018; 8(1)
[Pubmed]  [Google Scholar] [DOI]

 

Read this article